Allosteric control of βiI-tryptase by a redox active disulfide bond

Journal of Biological Chemistry

Volumn 288, Issue 48, 2013, Pages 34920-34929

  Cook, Kristina M ^a   McNeil, H Patrick ^a   Hogg, Philip J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; COVALENT BONDS; ENZYMES; RATE CONSTANTS; REDOX REACTIONS; SUBSTRATES;

ACTIVE SITE POCKET; ALLOSTERIC CONTROL; BIOLOGICAL PROCESS; BLOOD COAGULATION; CATALYTIC EFFICIENCIES; DIFFERENT SUBSTRATES; INFLAMMATORY MEDIATORS; REDOX POTENTIALS;

SULFUR COMPOUNDS;

BETA2 TRYPTASE; CYSTEINE; RECOMBINANT ENZYME; THIOREDOXIN; TRYPTASE; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL CELL; ARTICLE; CATALYSIS; CONTROLLED STUDY; DISULFIDE BOND; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; HYDROLYSIS; MAST CELL; MOUSE; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; STOICHIOMETRY;

EID: 84889026973     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.523506     Document Type: Article

References (62)

1. Rawlings, N. D., Morton, F. R., Kok, C. Y., Kong, J., and Barrett, A. J. (2008) MEROPS. The peptidase database. Nucleic Acids Res. 36, D320-D325
2. Di Cera, E. (2009) Serine proteases. IUBMB Life 61, 510-515
3. Fiorucci, L., and Ascoli, F. (2004) Mast cell tryptase, a still enigmatic enzyme. Cell. Mol. Life Sci. 61, 1278-1295
4. Trivedi, N. N., Tamraz, B., Chu, C., Kwok, P. Y., and Caughey, G. H. (2009) Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations. J. Allergy Clin. Immunol. 124, 1099-1105
5. Miller, J. S., Westin, E. H., and Schwartz, L. B. (1989) Cloning and characterization of complementary DNA for human tryptase. J. Clin. Invest. 84, 1188-1195
6. Vanderslice, P., Ballinger, S. M., Tam, E. K., Goldstein, S. M., Craik, C. S., and Caughey, G. H. (1990) Human mast cell tryptase. Multiple cDNAs and genes reveal a multigene serine protease family. Proc. Natl. Acad. Sci. U.S.A. 87, 3811-3815
7. Cairns, J. A. (2005) Inhibitors of mast cell tryptase β as therapeutics for the treatment of asthma and inflammatory disorders. Pulm. Pharmacol. Ther. 18, 55-66
8. Castells, M., and Schwartz, L. B. (1988) Tryptase levels in nasal-lavage fluid as an indicator of the immediate allergic response. J. Allergy Clin. Immunol. 82, 348-355
9. Jarjour, N. N., Calhoun, W. J., Schwartz, L. B., and Busse, W. W. (1991) Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction. Am. Rev. Respir. Dis. 144, 83-87
10. Buckley, M. G., Walters, C., Wong, W. M., Cawley, M. I., Ren, S., Schwartz, L. B., and Walls, A. F. (1997) Mast cell activation in arthritis. Detection of α- and β-tryptase, histamine and eosinophil cationic protein in synovial fluid. Clin. Sci. 93, 363-370
11. McNeil, H. P., Shin, K., Campbell, I. K., Wicks, I. P., Adachi, R., Lee, D. M., and Stevens, R. L. (2008) The mouse mast cell-restricted tetramer-forming tryptases mouse mast cell protease 6 and mouse mast cell protease 7 are critical mediators in inflammatory arthritis. Arthritis Rheum. 58, 2338-2346
12. Thakurdas, S. M., Melicoff, E., Sansores-Garcia, L., Moreira, D. C., Petrova, Y., Stevens, R. L., and Adachi, R. (2007) The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections. J. Biol. Chem. 282, 20809-20815
13. Schwertassek, U., Balmer, Y., Gutscher, M., Weingarten, L., Preuss, M., Engelhard, J., Winkler, M., and Dick, T. P. (2007) Selective redox regulation of cytokine receptor signaling by extracellular thioredoxin-1. EMBO J. 26, 3086-3097
14. Schwertassek, U., Weingarten, L., and Dick, T. P. (2007) Identification of redox-active cell-surface proteins by mechanism-based kinetic trapping. Sci STKE 2007, pl8
15. Ganderton, T., Wong, J. W., Schroeder, C., and Hogg, P. J. (2011) Lateral self-association of VWF involves the Cys2431-Cys2453 disulfide/dithiol in the C2 domain. Blood 118, 5312-5318
16. Gatlin, C. L., Kleemann, G. R., Hays, L. G., Link, A. J., and Yates, J. R., 3rd. (1998) Protein identification at the low femtomole level from silverstained gels using a new fritless electrospray interface for liquid chromatography- microspray and nanospray mass spectrometry. Anal. Biochem. 263, 93-101
17. Rothwarf, D. M., and Scheraga, H. A. (1992) Equilibrium and kinetic constants for the thiol-disulfide interchange reaction between glutathione and dithiothreitol. Proc. Natl. Acad. Sci. U.S.A. 89, 7944-7948
18. Nilsson, G., Blom, T., Kusche-Gullberg, M., Kjellén, L., Butterfield, J. H., Sundström, C., Nilsson, K., and Hellman, L. (1994) Phenotypic characterization of the human mast-cell line HMC-1. Scand. J. Immunol. 39, 489-498
19. Torchinski, M. (1974) Thiol and Disulfide Groups of Proteins, Consultants Bureau, New York
20. Pereira, P. J., Bergner, A., Macedo-Ribeiro, S., Huber, R., Matschiner, G., Fritz, H., Sommerhoff, C. P., and Bode, W. (1998) Human β-tryptase is a ring-like tetramer with active sites facing a central pore. Nature 392, 306-311
21. Huang, C., Friend, D. S., Qiu, W. T., Wong, G. W., Morales, G., Hunt, J., and Stevens, R. L. (1998) Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6. J. Immunol. 160, 1910-1919
22. Lillig, C. H., and Holmgren, A. (2007) Thioredoxin and related molecules. From biology to health and disease. Antioxid. Redox Signal. 9, 25-47
23. Yamada, Y., Nakamura, H., Adachi, T., Sannohe, S., Oyamada, H., Kayaba, H., Yodoi, J., and Chihara, J. (2003) Elevated serum levels of thioredoxin in patients with acute exacerbation of asthma. Immunol. Lett. 86, 199-205
24. Burke-Gaffney, A., Callister, M. E., and Nakamura, H. (2005) Thioredoxin. Friend or foe in human disease? Trends Pharmacol. Sci. 26, 398-404
25. Jikimoto, T., Nishikubo, Y., Koshiba, M., Kanagawa, S., Morinobu, S., Morinobu, A., Saura, R., Mizuno, K., Kondo, S., Toyokuni, S., Nakamura, H., Yodoi, J., and Kumagai, S. (2002) Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Mol. Immunol. 38, 765-772
26. Lemarechal, H., Allanore, Y., Chenevier-Gobeaux, C., Ekindjian, O. G., Kahan, A., and Borderie, D. (2006) High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis. Clin. Chim. Acta 367, 156-161
27. Alter, S. C., Kramps, J. A., Janoff, A., and Schwartz, L. B. (1990) Interactions of human mast cell tryptase with biological protease inhibitors. Arch. Biochem. Biophys. 276, 26-31
28. Huang, C. (1999) Human tryptases α and β/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft. J. Biol. Chem. 274, 19670-19676
29. Marquardt, U., Zettl, F., Huber, R., Bode, W., and Sommerhoff, C. (2002) The crystal structure of human α1-tryptase reveals a blocked substratebinding region. J. Mol. Biol. 321, 491-502
30. Selwood, T., Wang, Z. M., McCaslin, D. R., and Schechter, N. M. (2002) Diverse stability and catalytic properties of human tryptase α and β isoforms are mediated by residue differences at the S1 pocket. Biochemistry 41, 3329-3340
31. De Young, M. B., Nemeth, E. F., and Scarpa, A. (1987) Measurement of the internal pH of mast cell granules using microvolumetric fluorescence and isotopic techniques. Arch. Biochem. Biophys. 254, 222-233
32. Johnson, R. G., Carty, S. E., Fingerhood, B. J., and Scarpa, A. (1980) The internal pH of mast cell granules. FEBS Lett. 120, 75-79
33. Lagunoff, D., and Rickard, A. (1983) Evidence for control of mast cell granule protease in situ by low pH. Exp. Cell Res. 144, 353-360
34. Farr, M., Garvey, K., Bold, A. M., Kendall, M. J., and Bacon, P. A. (1985) Significance of the hydrogen ion concentration in synovial fluid in rheumatoid arthritis. Clin. Exp. Rheumatol. 3, 99-104
35. Geborek, P., Saxne, T., Pettersson, H., and Wollheim, F. A. (1989) Synovial fluid acidosis correlates with radiological joint destruction in rheumatoid arthritis knee joints. J. Rheumatol. 16, 468-472
36. Hunt, J. F., Fang, K., Malik, R., Snyder, A., Malhotra, N., Platts-Mills, T. A., and Gaston, B. (2000) Endogenous airway acidification. Implications for asthma pathophysiology. Am. J. Respir. Crit. Care Med. 161, 694-699
37. Kodric, M., Shah, A. N., Fabbri, L. M., and Confalonieri, M. (2007) An investigation of airway acidification in asthma using induced sputum. A study of feasibility and correlation. Am. J. Respir. Crit. Care Med. 175, 905-910
38. Fajardo, I., and Pejler, G. (2003) Formation of active monomers from tetrameric human β-tryptase. Biochem. J. 369, 603-610
39. Fukuoka, Y., and Schwartz, L. B. (2004) Human β-tryptase. Detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitors. Biochemistry 43, 10757-10764
40. Fukuoka, Y., and Schwartz, L. B. (2006) The B12 anti-tryptase monoclonal antibody disrupts the tetrameric structure of heparin-stabilized β-tryptase to form monomers that are inactive at neutral pH and active at acidic pH. J. Immunol. 176, 3165-3172
41. Hallgren, J., Lindahl, S., and Pejler, G. (2005) Structural requirements and mechanism for heparin-dependent activation and tetramerization of human βI- and βII-tryptase. J. Mol. Biol. 345, 129-139
42. Schwartz, L. B., Bradford, T. R., Littman, B. H., and Wintroub, B. U. (1985) The fibrinogenolytic activity of purified tryptase from human lung mast cells. J. Immunol. 135, 2762-2767
43. Ren, S., Lawson, A. E., Carr, M., Baumgarten, C. M., and Schwartz, L. B. (1997) Human tryptase fibrinogenolysis is optimal at acidic pH and generates anticoagulant fragments in the presence of the anti-tryptase monoclonal antibody B12. J. Immunol. 159, 3540-3548
44. Yousef, G. M., Elliott, M. B., Kopolovic, A. D., Serry, E., and Diamandis, E. P. (2004) Sequence and evolutionary analysis of the human trypsin subfamily of serine peptidases. Biochim. Biophys. Acta 1698, 77-86
45. Miyata, T., Kawabata, S., Iwanaga, S., Takahashi, I., Alving, B., and Saito, H. (1989) Coagulation factor XII (Hageman factor) Washington D.C. Inactive factor XIIa results from Cys-571-Ser substitution. Proc. Natl. Acad. Sci. U.S.A. 86, 8319-8322
46. Bush-Pelc, L. A., Marino, F., Chen, Z., Pineda, A. O., Mathews, F. S., and Di Cera, E. (2007) Important role of the Cys-191 Cys-220 disulfide bond in thrombin function and allostery. J. Biol. Chem. 282, 27165-27170
47. Wang, E. C., Hung, S. H., Cahoon, M., and Hedstrom, L. (1997) The role of the Cys191-Cys220 disulfide bond in trypsin. New targets for engineering substrate specificity. Protein Eng. 10, 405-411
48. Várallyay, E., Lengyel, Z., Gráf, L., and Szilágyi, L. (1997) The role of disulfide bond C191-C220 in trypsin and chymotrypsin. Biochem. Biophys. Res. Commun. 230, 592-596
49. Cook, K. M., and Hogg, P. J. (2013) Post-translational control of protein function by disulfide bond cleavage. Antioxid. Redox Signal. 18, 1987-2015
50. Hogg, P. J. (2013) Targeting allosteric disulphide bonds in cancer. Nat. Rev. Cancer 13, 425-431
51. Schmidt, B., Ho, L., and Hogg, P. J. (2006) Allosteric disulfide bonds. Biochemistry 45, 7429-7433
52. Schmidt, B., and Hogg, P. J. (2007) Search for allosteric disulfide bonds in NMR structures. BMC Struct. Biol. 7, 49
53. Wong, J. W., and Hogg, P. J. (2010) Analysis of disulfide bonds in protein structures. J. Thromb. Haemost. 8, 2345
54. Xu, S. Z., Sukumar, P., Zeng, F., Li, J., Jairaman, A., English, A., Naylor, J., Ciurtin, C., Majeed, Y., Milligan, C. J., Bahnasi, Y. M., Al-Shawaf, E., Porter, K. E., Jiang, L. H., Emery, P., Sivaprasadarao, A., and Beech, D. J. (2008) TRPC channel activation by extracellular thioredoxin. Nature 451, 69-72
55. Jiang, X. M., Fitzgerald, M., Grant, C. M., and Hogg, P. J. (1999) Redox control of exofacial protein thiols/disulfides by protein disulfide isomerase. J. Biol. Chem. 274, 2416-2423
56. Lackman, R. L., Jamieson, A. M., Griffith, J. M., Geuze, H., and Cresswell, P. (2007) Innate immune recognition triggers secretion of lysosomal enzymes by macrophages. Traffic 8, 1179-1189
57. Metcalfe, C., Cresswell, P., Ciaccia, L., Thomas, B., and Barclay, A. N. (2011) Labile disulfide bonds are common at the leucocyte cell surface. Open Biol. 1, 110010
58. Phan, U. T., Arunachalam, B., and Cresswell, P. (2000) γ-Interferon-inducible lysosomal thiol reductase (GILT). Maturation, activity, and mechanism of action. J. Biol. Chem. 275, 25907-25914
59. Alter, S. C., Metcalfe, D. D., Bradford, T. R., and Schwartz, L. B. (1987) Regulation of human mast cell tryptase. Effects of enzyme concentration, ionic strength and the structure and negative charge density of polysaccharides. Biochem. J. 248, 821-827
60. Schwartz, L. B., and Bradford, T. R. (1986) Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer. J. Biol. Chem. 261, 7372-7379
61. Di Cera, E. (2008) Thrombin. Mol. Aspects Med. 29, 203-254
62. Liang, G., Choi-Sledeski, Y. M., Shum, P., Chen, X., Poli, G. B., Kumar, V., Minnich, A., Wang, Q., Tsay, J., Sides, K., Kang, J., and Zhang, Y. (2012) A β-tryptase inhibitor with a tropanylamide scaffold to improve in vitro stability and to lower hERG channel binding affinity. Bioorg. Med. Chem. Lett. 22, 1606-1610